73 related articles for article (PubMed ID: 21219903)
1. Structural characterization of intracellular C-terminal domains of group III metabotropic glutamate receptors.
Seebahn A; Dinkel H; Mohrlüder J; Hartmann R; Vogel N; Becker CM; Sticht H; Enz R
FEBS Lett; 2011 Feb; 585(3):511-6. PubMed ID: 21219903
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of metabotropic glutamate receptor 7 peptides.
Isozumi N; Ohki S
Protein Expr Purif; 2010 Sep; 73(1):46-50. PubMed ID: 20363328
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification, and structural analysis of intracellular C-termini from metabotropic glutamate receptors.
Seebahn A; Sticht H; Enz R
Methods Enzymol; 2013; 520():257-79. PubMed ID: 23332704
[TBL] [Abstract][Full Text] [Related]
4. N-Glycosylation influences the structure and self-association abilities of recombinant nucleolin.
Losfeld ME; Leroy A; Coddeville B; Carpentier M; Mazurier J; Legrand D
FEBS J; 2011 Jul; 278(14):2552-64. PubMed ID: 21575138
[TBL] [Abstract][Full Text] [Related]
5. The trick of the tail: protein-protein interactions of metabotropic glutamate receptors.
Enz R
Bioessays; 2007 Jan; 29(1):60-73. PubMed ID: 17187376
[TBL] [Abstract][Full Text] [Related]
6. Night blindness-associated mutations in the ligand-binding, cysteine-rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking.
Zeitz C; Forster U; Neidhardt J; Feil S; Kälin S; Leifert D; Flor PJ; Berger W
Hum Mutat; 2007 Aug; 28(8):771-80. PubMed ID: 17405131
[TBL] [Abstract][Full Text] [Related]
7. Band 4.1 proteins are expressed in the retina and interact with both isoforms of the metabotropic glutamate receptor type 8.
Rose M; Dütting E; Enz R
J Neurochem; 2008 Jun; 105(6):2375-87. PubMed ID: 18373558
[TBL] [Abstract][Full Text] [Related]
8. Solution NMR structure and folding dynamics of the N terminus of a rat non-muscle alpha-tropomyosin in an engineered chimeric protein.
Greenfield NJ; Huang YJ; Palm T; Swapna GV; Monleon D; Montelione GT; Hitchcock-DeGregori SE
J Mol Biol; 2001 Sep; 312(4):833-47. PubMed ID: 11575936
[TBL] [Abstract][Full Text] [Related]
9. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
[TBL] [Abstract][Full Text] [Related]
10. Effects of varying the local propensity to form secondary structure on the stability and folding kinetics of a rapid folding mixed alpha/beta protein: characterization of a truncation mutant of the N-terminal domain of the ribosomal protein L9.
Luisi DL; Kuhlman B; Sideras K; Evans PA; Raleigh DP
J Mol Biol; 1999 May; 289(1):167-74. PubMed ID: 10339414
[TBL] [Abstract][Full Text] [Related]
11. Determining calmodulin binding to metabotropic glutamate receptors with distinct protein-interaction methods.
Lidwell K; Dillon J; Sihota A; O'Connor V; Pilkington B
Biochem Soc Trans; 2004 Nov; 32(Pt 5):868-70. PubMed ID: 15494036
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP-dependent protein kinase phosphorylates group III metabotropic glutamate receptors and inhibits their function as presynaptic receptors.
Cai Z; Saugstad JA; Sorensen SD; Ciombor KJ; Zhang C; Schaffhauser H; Hubalek F; Pohl J; Duvoisin RM; Conn PJ
J Neurochem; 2001 Aug; 78(4):756-66. PubMed ID: 11520896
[TBL] [Abstract][Full Text] [Related]
13. MacMARCKS interacts with the metabotropic glutamate receptor type 7 and modulates G protein-mediated constitutive inhibition of calcium channels.
Bertaso F; Lill Y; Airas JM; Espeut J; Blahos J; Bockaert J; Fagni L; Betz H; El-Far O
J Neurochem; 2006 Oct; 99(1):288-98. PubMed ID: 16987251
[TBL] [Abstract][Full Text] [Related]
14. Conformational analysis of a set of peptides corresponding to the entire primary sequence of the N-terminal domain of the ribosomal protein L9: evidence for stable native-like secondary structure in the unfolded state.
Luisi DL; Wu WJ; Raleigh DP
J Mol Biol; 1999 Mar; 287(2):395-407. PubMed ID: 10080901
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of dynamin II domains and initial studies on structure and function.
Dong J; Misselwitz R; Welfle H; Westermann P
Protein Expr Purif; 2000 Nov; 20(2):314-23. PubMed ID: 11049755
[TBL] [Abstract][Full Text] [Related]
16. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
[TBL] [Abstract][Full Text] [Related]
17. Domain organization of calbindin D28k as determined from the association of six synthetic EF-hand fragments.
Linse S; Thulin E; Gifford LK; Radzewsky D; Hagan J; Wilk RR; Akerfeldt KS
Protein Sci; 1997 Nov; 6(11):2385-96. PubMed ID: 9385641
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the interaction between the N-terminal extension of human cardiac troponin I and troponin C.
Ward DG; Brewer SM; Calvert MJ; Gallon CE; Gao Y; Trayer IP
Biochemistry; 2004 Apr; 43(13):4020-7. PubMed ID: 15049709
[TBL] [Abstract][Full Text] [Related]
19. Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.
Kim KS; Sun ZY; Wagner G; Reinherz EL
J Mol Biol; 2000 Sep; 302(4):899-916. PubMed ID: 10993731
[TBL] [Abstract][Full Text] [Related]
20. Structure and influence on stability and activity of the N-terminal propeptide part of lung surfactant protein C.
Li J; Liepinsh E; Almlén A; Thyberg J; Curstedt T; Jörnvall H; Johansson J
FEBS J; 2006 Mar; 273(5):926-35. PubMed ID: 16478467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
